首页> 外文期刊>Cancer Management and Research >CIP2A overexpression in Taiwanese oral cancer patients
【24h】

CIP2A overexpression in Taiwanese oral cancer patients

机译:台湾口腔癌患者中CIP2A过表达

获取原文
           

摘要

Introduction: Oral cancer is a prevalent form of cancer worldwide, particularly in Taiwan, and mechanisms involved in oral squamous cell carcinoma (OSCC) progression remain relatively unknown. Cancerous inhibitor of protein phosphatase 2A (CIP2A), an oncoprotein, is aberrantly expressed in many human malignant tumors including oral cancer. However, the expression and role played by CIP2A in oral cancer pathogenesis remain obscure. Methods: In this study, immunohistochemistry was used to analyze CIP2A expression between OSCC tissues and their adjacent noncancerous tissues. Furthermore, associations between CIP2A expression and histopathological parameters were investigated. Results: In this study, we showed that CIP2A was overexpressed in most of the OSCC tissues. High CIP2A expression was significantly associated with moderate/poor tumor differentiation ( P =0.02). No significant association was found between CIP2A expression and other clinical parameters. Kaplan–Meier analysis revealed that high CIP2A expression showed poorer survival rates than those with low CIP2A expression ( P =0.047). Multivariate Cox regression analysis indicated that CIP2A expression, N stage, American Joint Committee on Cancer stage and clinical therapy were independent prognostic factors for survival. Conclusion: Thus, our study suggests that CIP2A is an independent prognostic marker for OSCC and a novel target for OSCC treatment.
机译:简介:口腔癌是全世界(尤其是台湾地区)的一种普遍癌症,而口腔鳞状细胞癌(OSCC)进展涉及的机制仍然相对未知。蛋白磷酸酶2A(CIP2A)的癌性抑制蛋白(一种癌蛋白)在包括口腔癌在内的许多人类恶性肿瘤中异常表达。但是,CIP2A在口腔癌发病机理中的表达和作用仍然不清楚。方法:采用免疫组织化学方法分析OSCC组织及其邻近非癌组织之间CIP2A的表达。此外,研究了CIP2A表达与组织病理学参数之间的关联。结果:在这项研究中,我们表明CIP2A在大多数OSCC组织中过表达。 CIP2A高表达与中度/差度肿瘤分化显着相关(P = 0.02)。在CIP2A表达与其他临床参数之间未发现明显关联。 Kaplan–Meier分析显示,与低CIP2A表达相比,高CIP2A表达显示出较差的存活率(P = 0.047)。多元Cox回归分析表明,CIP2A表达,N期,美国癌症联合委员会分期和临床治疗是生存的独立预后因素。结论:因此,我们的研究表明CIP2A是OSCC的独立预后标志物,也是OSCC治疗的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号